Lindmik Pharmaceutical (Suzhou) Co., LTD. (hereinafter referred to as "Leming Pharmaceutical"), which focuses on the research and development and production of transdermal drug delivery, signed a strategic cooperation agreement with Jiuzhou Pharmaceutical Group (hereinafter referred to as "Jiuzhou Pharmaceutical"), the largest private pharmaceutical commercial enterprise in China, and the two sides will carry out all-round cooperation and exploration in the national retail channels of products in the future. Working together to meet the urgent clinical needs of patients with chronic musculoskeletal pain and osteoarthritis.
Mr. Gu Danhui, Chairman of Lindmik Pharmaceutical (Suzhou) Co., LTD., and Mr. Liu Dengpan, Vice chairman of Jiuzhou Pharmaceutical Group, witnessed the signing ceremony and delivered a speech. Mr. Ji Yongchang, Deputy General Manager of Leming Pharmaceutical (Suzhou) Co., LTD., and Ms. Liu Sufang, Deputy general manager and general manager of Jiuzhou Pharmaceutical Group, signed the strategic cooperation Framework Agreement on behalf of both parties.
In his speech, Mr. Gu Danhui, Chairman of Lindmik Pharmaceutical, said that Lindmik Pharmaceutical has been focusing on the research and development and industrialization of transdermal drug delivery technology, and there are two non-steroidal topical patches, flubiprofen gel paste and loxoprofen sodium gel paste, which are about to enter the commercialization stage and will provide more effective clinical solutions for patients with chronic muscle pain and osteoarthritis. As one of the leading private pharmaceutical commercial enterprises in China, relying on its "10,000 store alliance" strategy, Jiuzhou Tong has established a nationwide retail pharmacy network, which can provide in-depth distribution and other value-added services for Leming Pharmaceutical's products, and effectively help the implementation of the company's three-line strategy. We look forward to more comprehensive cooperation in the future.
Mr. Liu Dengpan, vice chairman of Kyushutong Pharmaceutical Group, said that as the only private enterprise among the four major pharmaceutical companies in the field of pharmaceutical business, the company has completed the layout of retail pharmacy business across the country with an efficient and flexible decision-making mechanism. Next, relying on the group's high share in the out-of-hospital market, we will give full play to the comprehensive service advantages of "pharmaceutical distribution + logistics distribution + product promotion" to help Leming Pharmaceutical complete the coverage of its products in the national retail market, so that high-quality drugs can benefit more patients. At the same time, we also hope to make use of the leading advantages of Leming Pharmaceutical in the field of transdermal drug delivery, and deepen cooperation between the two sides to jointly promote the development of China's health cause.
About Lindmik Pharmaceutical
Lindmik Pharmaceutical (Suzhou) Co., Ltd. is a high-tech pharmaceutical enterprise focusing on the research and development, production and sales of innovative pharmaceutical preparations. The company adheres to the dual-engine driven development strategy of independent research and development and international cooperation. The company has an independent research and development platform for various dosage forms in the field of transdermal drug delivery, and a number of transdermal products are about to enter the commercialization stage. Leming Pharmaceutical also continues to introduce other cutting-edge pharmaceutical technologies such as nano-loaded drugs and microsphere loaded drugs through international cooperation and development. Based on a deep understanding of the Chinese pharmaceutical market, Leming Pharmaceutical takes solving unmet clinical needs as the starting point, focuses on differentiated preparation innovation, has a complete R & D, production and sales system, and has a high growth rate.
About Kyushutong Pharmaceutical
Kyushutong Pharmaceutical Group Co., Ltd. is a technology-driven comprehensive service provider for the whole chain pharmaceutical industry. The company is based on the pharmaceutical circulation, logistics services and medical health and other major health industries. The main business includes digital pharmaceutical distribution and supply chain services, general brand promotion services, pharmaceutical industry and licensing business, digital retail, smart logistics and supply chain solutions, medical health and technology value-added services. Founded in 1985 at the beginning of the reform and opening up, and established in 1999 when private capital was allowed to enter the pharmaceutical circulation field, Kyushu Tongfa was listed on the Shanghai Stock Exchange in November 2010. Kyushu Tongfa is the largest private pharmaceutical commercial enterprise in China and ranks the fourth among Chinese pharmaceutical commercial enterprises. It is the first 5A logistics enterprise in the industry and the only enterprise awarded the national Ten intelligent warehousing logistics demonstration base; The company is ranked 207th in the "Top 500 Chinese Enterprises" and 68th in the "Top 500 Chinese Private Enterprises" in 2022.
Lindmik Pharmaceutical(Suzhou)Co.,Ltd is a high-tech pharmaceutical enterprise focusing on the research and development, production and sales of innovative pharmaceutical preparations.Equipped with a number of its own innovative R&D platform of dosage forms, including the transdermal drug delivery system, and at the same time, actively introducing the world’s leading nano-based drug delivery, microspheres drug delivery and other cutting-edge pharmaceutical technologies by means of “license in”, the company is a new rapidly developing company pharmaceutical companies that catches people’s eyes.
12th Floor, Building 5, Tianyun Plaza, 111 Wusongjiang Avenue, Guoxiang Street, Wuzhong District, Suzhou City
0512-66020899
0512-66022699
215124